Cerebrolysin: spectrum of activity and research data. Part 2
The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849693488168304640 |
|---|---|
| author | N. D. Bukreeva E. A. Rakityanskaya |
| author_facet | N. D. Bukreeva E. A. Rakityanskaya |
| author_sort | N. D. Bukreeva |
| collection | DOAJ |
| description | The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin on certain areas of the hippocampus and their function. The medicine has a unique organ-multimodal action on the brain, it is capable of metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity, detected in numerous experimental studies. The clinical efficacy of the medicine is confirmed by clinical trials performed based on GCP requirements. |
| format | Article |
| id | doaj-art-93f710c0d25844a38ddd1bb2f2ba4339 |
| institution | DOAJ |
| issn | 2313-7053 2713-055X |
| language | Russian |
| publishDate | 2018-07-01 |
| publisher | Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation |
| record_format | Article |
| series | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| spelling | doaj-art-93f710c0d25844a38ddd1bb2f2ba43392025-08-20T03:20:23ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2018-07-0102415216Cerebrolysin: spectrum of activity and research data. Part 2N. D. Bukreeva0E. A. Rakityanskaya1ФГБУ «ФМИЦПН им. В.П. Сербского» Минздрава РоссииФГБУ «ФМИЦПН им. В.П. Сербского» Минздрава РоссииThe results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin on certain areas of the hippocampus and their function. The medicine has a unique organ-multimodal action on the brain, it is capable of metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity, detected in numerous experimental studies. The clinical efficacy of the medicine is confirmed by clinical trials performed based on GCP requirements.https://www.bekhterevreview.com/jour/article/view/16церебролизинлекарственная терапияпсихиатрияневрологияфармакологиянейропротекторметаболическая регуляцияфункциональная нейромодуляцияcerebrolysinmedical therapypsychiatryneurologypharmacologyneuroprotectivemetabolic regulationfunctional neuromodulationneurotrophic activity |
| spellingShingle | N. D. Bukreeva E. A. Rakityanskaya Cerebrolysin: spectrum of activity and research data. Part 2 Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева церебролизин лекарственная терапия психиатрия неврология фармакология нейропротектор метаболическая регуляция функциональная нейромодуляция cerebrolysin medical therapy psychiatry neurology pharmacology neuroprotective metabolic regulation functional neuromodulation neurotrophic activity |
| title | Cerebrolysin: spectrum of activity and research data. Part 2 |
| title_full | Cerebrolysin: spectrum of activity and research data. Part 2 |
| title_fullStr | Cerebrolysin: spectrum of activity and research data. Part 2 |
| title_full_unstemmed | Cerebrolysin: spectrum of activity and research data. Part 2 |
| title_short | Cerebrolysin: spectrum of activity and research data. Part 2 |
| title_sort | cerebrolysin spectrum of activity and research data part 2 |
| topic | церебролизин лекарственная терапия психиатрия неврология фармакология нейропротектор метаболическая регуляция функциональная нейромодуляция cerebrolysin medical therapy psychiatry neurology pharmacology neuroprotective metabolic regulation functional neuromodulation neurotrophic activity |
| url | https://www.bekhterevreview.com/jour/article/view/16 |
| work_keys_str_mv | AT ndbukreeva cerebrolysinspectrumofactivityandresearchdatapart2 AT earakityanskaya cerebrolysinspectrumofactivityandresearchdatapart2 |